Literature DB >> 20844957

Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data.

Peter Richardson1, Louise Henderson, Jessica A Davila, Jennifer R Kramer, Conar P Fitton, G John Chen, Hashem B El-Serag.   

Abstract

BACKGROUND: The purpose of alpha-fetoprotein (AFP) and abdominal ultrasound (US) cannot be discerned in administrative data. AIM: We developed an algorithm to identify AFP and US used as surveillance tests for hepatocellular carcinoma (HCC).
METHODS: We evaluated 300 AFP and 301 US tests from a VA database. Surveillance predictors in the administrative files (diagnoses, labs) were examined in logistic regression models. We calculated model-based probabilities of HCC surveillance status, and developed classification procedures using single and multiple imputation methods.
RESULTS: The predictors of surveillance intent for AFP were absence of alcoholism, abdominal pain, ascites, diabetes and high AST levels. For US, the predictors of surveillance were prior AFP testing and HIV status and absence of abdominal pain, ascites, or drug dependence. For AFP classification, single imputation compared favorably with multiple imputation, both showing robustness in discrimination and calibration. For US both approaches were less robust in discrimination and calibration which was more moderate in multiple imputation than single imputation.
CONCLUSIONS: Predictive algorithms in administrative files can be used to identify AFP performed for HCC surveillance, however, the intent of US is more difficult to identify.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20844957     DOI: 10.1007/s10620-010-1387-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

3.  Modeling and variable selection in epidemiologic analysis.

Authors:  S Greenland
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

4.  Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

Authors:  Franco Trevisani; Stefania De Notariis; Gianludovico Rapaccini; Fabio Farinati; Luisa Benvegnù; Marco Zoli; Gian Luca Grazi; Poggio Paolo Del; NolfoMariaAnna Di; Mauro Bernardi
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

Review 5.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Authors:  Hashem B El-Serag; K Lenhard Rudolph
Journal:  Gastroenterology       Date:  2007-06       Impact factor: 22.682

6.  The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases.

Authors:  J R Kramer; J A Davila; E D Miller; P Richardson; T P Giordano; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2007-11-08       Impact factor: 8.171

7.  Clinical Case Registries: simultaneous local and national disease registries for population quality management.

Authors:  Lisa I Backus; Sergey Gavrilov; Timothy P Loomis; James P Halloran; Barbara R Phillips; Pamela S Belperio; Larry A Mole
Journal:  J Am Med Inform Assoc       Date:  2009-08-28       Impact factor: 4.497

8.  Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

Authors:  A Singal; M L Volk; A Waljee; R Salgia; P Higgins; M A M Rogers; J A Marrero
Journal:  Aliment Pharmacol Ther       Date:  2009-04-08       Impact factor: 8.171

Review 9.  Diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hashem B El-Serag; Jorge A Marrero; Lenhard Rudolph; K Rajender Reddy
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

  9 in total
  10 in total

1.  Predictive algorithms: uses and limitations.

Authors:  Janice H Jou; Deborah A Fisher
Journal:  Dig Dis Sci       Date:  2010-11       Impact factor: 3.199

2.  The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.

Authors:  Donna L White; Peter Richardson; Nabiha Tayoub; Jessica A Davila; Fasiha Kanwal; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2015-10-28       Impact factor: 22.682

3.  Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries.

Authors:  Hanna K Sanoff; YunKyung Chang; Joseph M Stavas; Til Stürmer; Jennifer Lund
Journal:  J Natl Compr Canc Netw       Date:  2015-09       Impact factor: 11.908

4.  Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.

Authors:  Debra T Choi; Hye-Chung Kum; Sulki Park; Robert L Ohsfeldt; Yu Shen; Neehar D Parikh; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2018-10-26       Impact factor: 11.382

5.  Core implementation strategies for improving cirrhosis care in the Veterans Health Administration.

Authors:  Vera Yakovchenko; Timothy R Morgan; Edward J Miech; Brittney Neely; Carolyn Lamorte; Sandra Gibson; Lauren A Beste; Heather McCurdy; Dawn Scott; Rachel I Gonzalez; Angela M Park; Byron J Powell; Jasmohan S Bajaj; Jason A Dominitz; Maggie Chartier; David B Ross; Matthew J Chinman; Shari S Rogal
Journal:  Hepatology       Date:  2022-03-17       Impact factor: 17.298

6.  Surveillance for hepatocellular carcinoma in a Medicaid cirrhotic population.

Authors:  Lena B Palmer; Michael D Kappelman; Robert S Sandler; Paul H Hayashi
Journal:  J Clin Gastroenterol       Date:  2013-09       Impact factor: 3.062

7.  Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors.

Authors:  Jessica A Davila; Jennifer R Kramer; Zhigang Duan; Peter A Richardson; Gia L Tyson; Yvonne H Sada; Fasiha Kanwal; Hashem B El-Serag
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

8.  Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.

Authors:  Hla-Hla Thein; Michael A Campitelli; Latifa T Yeung; Ahmad Zaheen; Eric M Yoshida; Craig C Earle
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

9.  Developing model-based algorithms to identify screening colonoscopies using administrative health databases.

Authors:  Maida J Sewitch; Mengzhu Jiang; Lawrence Joseph; Robert J Hilsden; Alain Bitton
Journal:  BMC Med Inform Decis Mak       Date:  2013-04-10       Impact factor: 2.796

10.  Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.

Authors:  Hanna K Sanoff; YunKyung Chang; Jennifer L Lund; Bert H O'Neil; Stacie B Dusetzina
Journal:  Oncologist       Date:  2016-05-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.